West Pharmaceutical Services Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Total Cash from Operations: $159.6M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $81.5M | 51.1% |
| Other Investing | $9.9M | 6.2% |
| Dividends Paid | $20.4M | 12.8% |
| Stock Repurchases | $3.1M | 1.9% |
| Working Capital | $28.9M | 18.1% |
| Other | $15.8M | 9.9% |
| Net Cash Flow | $0 | 0.0% |